ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 330500 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 330500; 2) Community: the network communities that were significantly associated with the response to NSC 330500; 3) Molecule: the relationships between components within communities and NSC 330500; 4) MDR: the compounds that were significantly associated with the NSC 330500.

NSC Compound Enrichment Correlation
NSC 683661 Acetic acid, amino-, 9-[[(amino)carbonyl]oxy]-13-(2-amino- 1-oxoethoxy)-8,14-dimethoxy-4,10,12,16-tetramethyl- 3,20,22-trioxo-19-[(2-propenyl)amino]-2-azabicyclo [16.3.1]docosa-1(21),4,6,10,18-pentae 0.0222343516878698 0.53705823
NSC 692580 Null 0.0222343516878698 0.42332077
NSC 697886 17-Demethoxy-17-allylamino geldanamycin-11-[4-(dimethylamino)butyrate] 0.0222343516878698 0.52358312
NSC 699139 Null 0.0222343516878698 0.27350886
NSC 700913 Null 0.0222343516878698 0.56347329
NSC 702734 Null 0.0222343516878698 0.34206551
NSC 706995 Entinostat 0.0222343516878698 0.12449373
NSC 714187 3,11-difluoro-6,8,13-trimethyl-8H-quino[4,3,2-kl]acridinium methosulfate 0.0222343516878698 0.45790329
NSC 727987 NSC 708783 incorporated in micelles, 0.20% (w/w) of drug 0.0222343516878698 0.17919299
NSC 736115 6-(3-Azidopropyl)-5,6-dihydro-9-methyl-3-nitro-5,11-dioxo-11 H-indeno[1,2-c]isoquinoline 0.0222343516878698 0.31432696
Total:121  Current:71    [First] [Prev] [Next] [Last]